Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Cytokinetics Announces Health Canada Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy
-
Papa Johns Summons a Halloween Favourite: The Jack-o’-Lantern Pizza Returns
-
NXGen Brands Announces Completed BLAQclouds Control Acquisition and Zero Outstanding Debt
-
Duchess Restaurants Selects Beyond Oil as Frying Standard Across the Chain
-
SL Green Refinances 245 Park Avenue for $2.0 Billion
-
Caliber CEO Chris Loeffler to Speak on Public Companies & Crypto Panel at Tokenize! Las Vegas 2026
-
Glass House Brands Reports Preliminary Unaudited Third Quarter Financial Results and Resignation of John Nichols Jr. from Board of Directors
-
REPEAT - Cambria Gold Mines Intersects 98.56 g/t Gold over 8.2 Metres at the Silver Coin Deposit, Premier Gold Project
-
Chase Bell and Lira Bring Their “Do Me” Collaboration to Hollywood in a Sold-Out Performance at East West Studios
-
Rekor Systems Takes Legal Action Against Former Director Following Extensive Investigation into Alleged Breaches of Fiduciary Duty in Connection with a December 2025 Financing with a Hedge Fund
-
Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at IDWeek 2026
-
Biogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Week
-
Brutus Mining Inc. Announces Technical Data for the CW Copper Project in South-Central British Columbia
-
“The Great Cities of Italy”: Italpreziosi presents a silver collection dedicated to the beauty of the country
-
ChemoMetec A/S invites to conference call on November 6, 2026, at 3:00 PM CET to present Q1 2026/27 financial results
-
Georgia Personal Injury Statute of Limitations Explained in HelloNation Featuring Personal Injury Attorney D. Seth Holliday
-
EyePoint Announces Strategic Prioritization
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Form 8.5 (EPT/RI)-Advanced Medical Solutions Group plc
-
Form 8.5 (EPT/RI)-Pollen Street Group Limited
-
Kane Launches New Corporate Brand and Redesigned Website
-
Kraig Biocraft Laboratories Selected to Present to the International Sericultural Commission Congress on the Impact of Bioengineering on Commercial Silk Markets
-
Calian confirms Will Majic as Chief Financial Officer and appoints Kristine McTaggart President, Essential Industries
-
Facephi makes the leap from identity verification to continuous protection against digital fraud with its new platform
-
Form 8.5 (EPT/RI)-SThree Plc
-
Correction: ASC Energy PLC 2056 Noteholder Extraordinary Resolution
-
HPQ Silicon Partners with Open Markets to Scale Its Battery Business into a Standalone Company and Pursue a Listing on a Major U.S. Exchange
-
Haleon Launches ‘Haleon Health House,’ a One-Day Interactive Wellness Pop-Up in Toronto
-
Tonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Pain
-
Copper Road Announces Management Changes
-
Seraxis and Sernova Announce Appointment of Former FDA Medical Officer Dr. Patricia Beaston as Chief Medical Officer of Seraxis and Post Merger BetaNova Biotherapeutics
-
Erdene Provides Q3 2026 Update and Notice of Conference Call and Webcast
-
Major Drilling Announces Renewal of Normal Course Issuer Bid
-
Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM
-
Kamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026
-
Xanadu Secures Up to USD $10 Million in Additional DARPA Support to Accelerate Quantum R&D Roadmap
-
EyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMD
-
aTyr Pharma Announces Research Collaboration with Montefiore Einstein
-
Sylogist Announces CFO Transition, Appoints David Miller as Chief Operating Officer
-
Origin Agritech Announces Strategic Provincial Distribution Agreement for Corn Seeds in Shandong Province and Receives RMB 2.9 Million in Initial Payments
-
Attention Long-Term Shareholders of Aardvark Therapeutics, Inc. (NASDAQ: AARD); Coastal Financial Corporation (NASDAQ: CCB); Hub Group, Inc. (NASDAQ: HUBG); and Power Solutions International, Inc. (NA
-
EquipmentShare Raises 2026 Financial Outlook on Strong Performance and Customer Demand
-
Teamshares Retires Legacy Credit Facility with Term Loan Maturing 4Q 2030
-
Bioxytran Completes Production of Two Dietary Supplements: V-LO® for Immune Health and A-SUQAR® for Healthy Blood Sugar
-
Xanadu Secures Up to USD $10 Million in Additional DARPA Support to Accelerate Quantum R&D Roadmap
-
MC Brazil Downstream Trading S.à r.l. Announces Increase in Tender Offer Consideration and Total Consideration in Connection with Its Tender Offer for Any and All of Its Outstanding 7.250% Senior Sec
-
Disc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)
-
Marker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancer
-
Agility Robotics Announces Audit Committee Chair for Planned Public-Company Board
-
Iovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026
